TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: leg extension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: fat-free mass (FFM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 4-m gait speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Physical functioning
Primary endpoint: Provision of home-based monitoring or telemonitoring
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Median antifebrile onset time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median antifebrile recovery time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disappearance rate of main symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PWS erythema improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in SRED symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cogmed Index Improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Backward Digit Span
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glasgow Hearing Aid Benefit Profile, Initial Disability subscale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: enhanced sleepiness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: higher daytime sleepiness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduced psychomotor vigilance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vertical probing depth reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: horizontal probing depth reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gingival recession reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduced anger
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: postoperative deviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: exodrift at 12 months follow up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean effect of MR plication and resection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative incidence of non-cardiovascular death
Endpoint domain: Mortality/survival
Primary endpoint: Cumulative incidence of undetermined deaths
Endpoint domain: Mortality/survival
Primary endpoint: Changes in carotid and/or femoral DUS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: CIMT reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 30% or more superior visual field improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of anti-drug antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Patient-centred attitudes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: SPCM posture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TCMS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AFT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: object recognition improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: weekly minutes of PA implemented
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median early postoperative blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Rate of late postoperative bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Urinary Bother
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ultrasonography task performance scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ultrasonographic image identification MCQ test scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postural balance assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discrimination of fallers from nonfallers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in foot functionality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TSAT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hepcidin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: return visits for continued or worsened symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average accuracy of SDA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cohen's kappa coefficient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SDA sensitivities to identify balanced knee
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prohibited MRTP claims
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Descriptors implying reduced harm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of imagery on packaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: International Prostatic Symptomatic Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of ostomy complications
Endpoint domain: Adverse events/effects
Primary endpoint: 3D deviation in implant position
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: angle deviations between implants (parallelism)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: carbon monoxide confirmed ppa
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ODI success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ZCQ success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MMC excellent results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for TURBT
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Clinically significant side effects
Endpoint domain: Adverse events/effects
Primary endpoint: Vaccine-specific antibody concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction in agitation/aggression scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of young MSM with STD symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of young MSM receiving more than one joint testing
Endpoint domain: Physiological/clinical
Primary endpoint: Fewer attentional lapses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Less emotion regulation difficulties
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Greater mental toughness
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Freedom from Local Progression (FFLP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prosthetic side sagittal plane hip range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time until exhaustion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Operative time for laparoscopic staging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: improvement in state mindfulness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: performance in the Trail‐making task
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Risk of confirmed disability progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of CDA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence and rates of confirmed hypoglycaemia
Endpoint domain: Adverse events/effects
Primary endpoint: PRG procedural time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade 3/4 treatment-related adverse event rates
Endpoint domain: Adverse events/effects
Primary endpoint: surface staining
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: interproximal contacts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antigen reactivity of alkaline phosphatase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intensity of osteocalcin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of TRAP-positive cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean change from baseline in CDR-SB score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of patients with a normal Vitamin B12 level at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of chronic respiratory health symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: decreased uncertainty
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: decreased estimated threat likelihood
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: increased responsibility of others
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: total IIEF score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: numeric rating scale for chest pain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: FPG, 2-h OGTT and HbA1c levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Peak glucose levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Hypoxemia
Endpoint domain: Adverse events/effects
Primary endpoint: Severe bradycardia
Endpoint domain: Adverse events/effects
Primary endpoint: Admission to the PICU
Endpoint domain: Mortality/survival
Primary endpoint: Admission to the hospital
Endpoint domain: Mortality/survival
Primary endpoint: Completion rate for daily assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient engagement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of any STI
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Mycoplasma genitalium
Endpoint domain: Adverse events/effects
Primary endpoint: HPV vaccine initiation coverage change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SCD risk score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Composite outcome of death due to cardiovascular causes, first hospitalization for heart failure, and first outpatient episode of symptomatic heart failure
Endpoint domain: Mortality/survival
Primary endpoint: Quadriceps EMG amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Migraine attack days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Migraine symptom scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endurance time variance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: post-PIVC anxiety scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: post-PIVC pain scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of anemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Length of hospital and ICU stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Recurrence of cysts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrent episodes of atrial fibrillation within 1 yr
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mean score changes in skin and consultation subscales of the practice category
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Time interval to defibrillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients achieving modified Rankin Scale scores of 0-2 at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preterm birth at <28 weeks of gestation
Endpoint domain: Physiological/clinical
Primary endpoint: Vaccine efficacy against symptomatic Covid-19
Endpoint domain: Mortality/survival
Primary endpoint: Vaccine efficacy against moderate-to-severe disease
Endpoint domain: Mortality/survival
Primary endpoint: Cumulative incidence of TB or death
Endpoint domain: Mortality/survival
Primary endpoint: Postoperative venous thromboembolism
Endpoint domain: Adverse events/effects
Primary endpoint: Major surgery related bleeding in the first postoperative week
Endpoint domain: Adverse events/effects
Primary endpoint: delirium-free and coma-free days alive
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of neonatal respiratory illness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Average cost of removing LSCP
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Average days of lost productivity
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of patients with NRS score decreased by ≥50%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Episodes of breakthrough pain (BTP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive neutralization response against SARS-CoV-2 variants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Receipt of mammogram or stool test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Receipt of both mammogram and stool test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma oxalate level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Detection rate of recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ex-SRES score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: children's cognition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Death or disability classification
Endpoint domain: Mortality/survival
Primary endpoint: In-hospital death classification
Endpoint domain: Mortality/survival
Primary endpoint: Cardiac readmission rates at 5 years
Endpoint domain: Mortality/survival
Primary endpoint: Readmission rates for all causes at 5 years
Endpoint domain: Mortality/survival
Primary endpoint: Adequate relief of IBS-type symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical function on the FACIT-F
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Emotional wellbeing on the FACIT-F
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cumulative fluid intake on the ICU
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative urinary output until ICU discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: ICU fluid balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early PPI rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Restrained eating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Orthorexia nervosa tendencies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interleukin 1‐β (IL1‐β) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: HU loss at L4-5
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of osteoporosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain score on POD 7
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life scores (UW QOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Return to work (median days)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Response rate to clinic-based mailings
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Diagnosis of GIST
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade 3 oral pain
Endpoint domain: Adverse events/effects
Primary endpoint: Grade 3 dysphagia
Endpoint domain: Adverse events/effects
Primary endpoint: Total dose of morphine needed to treat postoperative pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative pain at rest (VAS-R)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative pain during walking (VAS-W)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ECOG status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postextubation VAS score at rest and deep breathing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: chronic inguinodynia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: post operative pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain level during tattooing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction with the tattooing process
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cosmetic quality of tattoos
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to acquire data from phototrichograms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of hair counting and length measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reproducibility of the algorithm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptom scores of qi deficiency syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased density of the left dorsolateral prefrontal cortex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mucosal Disease (MD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of packed RBC units transfused
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: sprint execution time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean plasma ASA concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean plasma SA concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean plasma ASA AUC0-last
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical effectiveness of celiprolol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in competencies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FOR severity improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relaxation skills practice 3+ days/week
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Muscle power enhancements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of lower endoscopies
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Physical quality of life (PCS score)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Area under the curve (AUC) for blood glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean reading self-confidence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Likelihood of selecting rectal STI test vs urethral test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of women with acceptable UIC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of women with less and excessive UIC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: child language competence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: event‐related desynchronization (ERD) of alpha rhythm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: classification accuracy between left‐ and right‐hand MI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes